Advertisement

Open-Label Trial of the Use of Minocycline in the Treatment of Asthma

Summary

The tetracycline minocycline has, in addition to its anti-infective properties,
anti-inflammatory properties which may be of use in the treatment of asthma. This study
evaluates the benefit of minocycline as add-on therapy for adults with asthma.

Description

Adult asthmatic (ages 18 to 75 years) with a history of moderate to severe persistent asthma
are given minocycline capsules as add-on therapy for treatment of asthma. Treatment is for
one year. Dosing begins at 150 mg twice daily and can increase every eight weeks by 50mg BID
to a maximum of 250 mg twice daily. This is as per patient tolerance as minocycline can
cause dizziness and stomach upset, as well as effects of liver enzymes.Patients undergo
routine blood toxicity screens every two months, at which time spirometry is performed
Exclusion criteria: pregnant women (adequate contraception in mandated) previous history of
hypersensitivity to tetracyclines, chronic liver disease Outcome measures: improvement in
FEV1 and other spirometric parameters, decrease in oral steroid requirements, change in
total serum IgE, improvement in quality of life

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Asthma

Intervention

minocycline

Location

SUNY Downstate Medical Center
Brooklyn
New York
United States
11203

Status

Active, not recruiting

Source

State University of New York - Downstate Medical Center

Results (where available)

View Results

Links

MESH Definitions

Minocycline

A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.

Asthma, Exercise-induced

Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it).

Anti-asthmatic Agents

Drugs that are used to treat asthma.

Orciprenaline

A beta-adrenergic agonist used in the treatment of asthma and bronchospasms.

Tretoquinol

An adrenergic beta-agonist used as a bronchodilator agent in asthma therapy.

 Clinical Trials 807 Associated Clinical Trials :: Search

 PubMed Articles 1688 Associated PubMed Articles :: Search

Advertisement

Associated Content for this Trial

Advertisement

Searches Linking to this Page

minocycline for asthma